Item Number: EQUIPA
Equip Artervac Emulsion for Injection for Horses and Ponies
For the active immunisation of horses and ponies against equine arteritis in order to reduce clinical signs and shedding of virus in nasal secretion after infection.
Onset of immunity: 3 weeks post primary vaccination.
Duration of immunity: 6 months.
Dosage and administration
1ml dose per horse to be administered by intramuscular injection.
A single dose should be administered two times with an interval of 3-6 weeks from an age of nine months onwards.
Booster vaccinations are recommended every 6 months.
Advice on correct administration:
Shake well before use.
Contra-indications, warnings, etc
Do not use in sick animals.
Minor transient (1 to 5 days) increase in body temperature (<40°C) was observed in both clinical studies and field trials in approximately 20% of horses vaccinated. Transient local reactions (for usually 2 to 3 days) were observed in up to 20% of horses vaccinated. The swellings were usually less than 4 cm in diameter, but the swelling (lasting for 5 days) in one horse was recorded as being 20cm. All swellings resolved. Systemic reactions were observed which included depression (1%), ocular and nasal discharge (8%), urticaria (<1%) and oedema of the legs, abdomen and scrotum (<1%).
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
Do not use in pregnant mares.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Equine viral arteritis (EVA) is a notifiable disease in the UK. Vaccinated horses will become seropositive and therefore it is recommended that they are blood tested prior to primary vaccination to demonstrate that they were previously seronegative. Details of blood testing and vaccination schedule should be recorded in the horse passport.
Special precautions for use in animals:
In the event of an allergic or anaphylactic reaction, adrenaline should be administered intramuscularly. Vaccination does not prevent infection. Vaccination does not have an effect on the shedding of EAV by previously infected carrier stallions.
The effect of the vaccine on the fertility of breeding stallions has not been investigated. Under some national legislation EVA is a notifable disease (UK). Please refer to the national product literature for recommendations on vaccination to comply with this legislation.
Animals that have received immunosuppressive drugs (e.g. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed.
Administration of a twofold overdose has no influence on the systemic reactions to vaccination as described in section "Adverse Reactions". Local swellings (<4 cm in size) were observed in 80% of horses administered two doses of vaccine, these swellings were observed for one day only.
Do not mix with any other veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician.
Keep out of reach and sight of children.
Store and transport refrigerated (2°C - 8°C).
Protect from light. Do not freeze.
Do not use after the expiry date stated on the carton label after EXP. (abbreviation used for expiry date).
Box containing 1 sachet of 1 syringe of 1 dose.
Box containing 10 sachets of 1 syringe of 1 dose.
Not all pack sizes may be marketed.